User profiles for VALÉRIE DEVAUCHELLE-PENSEC

Valérie Devauchelle-Pensec

EA2216 INSERM ERI29
Verified email at chu-brest.fr
Cited by 10394

[HTML][HTML] COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

…, F Detree, V Devauchelle-Pensec… - The Lancet …, 2021 - thelancet.com
Background Various observations have suggested that the course of COVID-19 might be
less favourable in patients with inflammatory rheumatic and musculoskeletal diseases …

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

…, JJ Dubost, S Rist, A Saraux, V Devauchelle-Pensec… - Jama, 2014 - jamanetwork.com
Importance Primary Sjögren syndrome is a systemic autoimmune disease characterized by
mouth and eye dryness, pain, and fatigue. Hydroxychloroquine is the most frequently …

Treatment of primary Sjögren syndrome with rituximab: a randomized trial

V Devauchelle-Pensec, X Mariette… - Annals of internal …, 2014 - acpjournals.org
… measure reported by Devauchelle-Pensec is attainment of a … Devauchelle-Pensec reports
significant improvement for … to 5-6 years reported by Devauchelle-Pensec (1) and Meijer (4 ) …

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity …

…, V Le Guern, V Devauchelle-Pensec… - Annals of the …, 2016 - ard.bmj.com
Objectives To define disease activity levels, minimal clinically important improvement (MCII)
and patient-acceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) …

Improvement of Sjögren's syndrome after two infusions of rituximab (anti‐CD20)

V DevauchellePensec, Y Pennec… - Arthritis care & …, 2007 - Wiley Online Library
Valérie Devauchelle-PensecValérie Devauchelle-PensecValérie Devauchelle-Pensec

Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: toward new diagnostic criteria?

…, A Saraux, V DevauchellePensec - Arthritis & …, 2013 - Wiley Online Library
Valérie Devauchelle-PensecDevauchelle-Pensec had full access to all of the data in the
study and takes responsibility for the integrity of the data and the accuracy of the data analysis. …

[HTML][HTML] A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome

…, G Barturen, G Desachy, V Devauchelle-Pensec… - Nature …, 2021 - nature.com
There is currently no approved treatment for primary Sjögren’s syndrome, a disease that
primarily affects adult women. The difficulty in developing effective therapies is -in part- because …

Treatment of primary Sjögren syndrome

…, JO Pers, V Devauchelle-Pensec - Nature Reviews …, 2016 - nature.com
Primary Sjögren syndrome (pSS) is a progressive autoimmune disease characterized by
sicca and systemic manifestations. In this Review, we summarize the available data on topical …

B cells in Sjögren's syndrome: from pathophysiology to diagnosis and treatment

D Cornec, V Devauchelle-Pensec, GJ Tobón… - Journal of …, 2012 - Elsevier
Primary Sjögren's syndrome (pSS) is a chronic autoimmune systemic disease, characterized
by a lymphoplasmocytic infiltration and a progressive destruction of salivary and lachrymal …

Diagnostic value of labial minor salivary gland biopsy for Sjögren's syndrome: a systematic review

…, JO Pers, A Saraux, V Devauchelle-Pensec - Autoimmunity …, 2013 - Elsevier
OBJECTIVES: To assess the diagnostic value of minor salivary gland biopsy (MSGB) for
primary Sjögren's syndrome (pSS). METHODS: Systematic review of studies retrieved from …